Articles
Benchmarking, Products and Services Contracting, Distribution, Financial Management, Lean/Six Sigma, Strategic Planning
Global Unique Device Identification Database (GUDID) Draft Guidance for Industry
By Center for Devices and Radiological Health, Informatics Staff, U.S. Department of Health and Human Services Food and Drug Administration, AHRMM
This page provides information about submitting data to the database for device Labelers, entities responsible for providing the data to the GUDID.
Career/Professional Development
Contracts Assistant
To provide administrative support to the TCH IDS contracts process.
Capital Equipment, Distribution, Regulations and Regulatory Advocacy, Procurement
IRS Issues Final Rule Implementing Medical Device Excise Tax
An announcement of the Final Rule issued by the IRS.
Cost Management, Financial Management, Regulations and Regulatory Advocacy, Procurement
Medical Device Excise Tax - What You Should Know
By AHRMM
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013. The tax is intended to provide an estimated $20 billion in tax revenues to help pay for the expansion of health coverage to 32 million uninsured Americans. Healthcare supply chain leaders have until May 7, 2012, to comment on the way in which the Internal Revenue Service (IRS) intends to implement this new tax.
Capital Equipment, Clinical Resource Management (CRM), Cost Management, Cost, Quality and Outcomes (CQO) Movement, Physician Preference Items (PPI), Strategic Sourcing, Value Analysis
Senior Contract Specialist
Senior Contract Specialist job description.
Pharmacy, Suppliers, Logistics
IV Strategies for Disruptions - How to Guide
By AHRMM
How-to guide to managing IV disruptions.
Products and Services Contracting, Legislation and Legislative Advocacy, Physician Preference Items (PPI), Regulations and Regulatory Advocacy, Suppliers, Procurement
Medical Device Tax Next Steps
By AHRMM
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Cost, Quality and Outcomes (CQO) Movement, Data Standards, Materials Management Information System (MMIS), Regulations and Regulatory Advocacy, Suppliers, Leadership
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
By AHRMM
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Change Management, Clinical Resource Management (CRM), Cost Management, Cost, Quality and Outcomes (CQO) Movement, Strategic Sourcing, Strategic Planning
Supply Chain Services Professional's Role in Achieving the Institute of Medicine's Six Aims for Improvement
By AHRMM
In 2001 the Institute of Medicine (IOM) published
Disaster/Outbreak Preparedness, Legislation and Legislative Advocacy, Regulations and Regulatory Advocacy, Procurement
Guidance for Writing Comments
By AHRMM
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision making.